HIGHLIGHTS
- who: Bijender Kumar et al. from the des Cordeliers (CRC), France Vanderbilt University, United States have published the article: Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia, in the Journal: (JOURNAL)
- what: This study provides a proof-of-concept for a multifaceted approach to optimize CB-MKs as a consistently available source of off-the-shelf platelets that may be beneficial for alleviating the constraints on the platelet inventory.
- how: Short durations of KD045 treatment also induced dose-dependent reductions in pMYPT1(Thr696) (p=0.0013 p=0 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.